This cohort study identifies patient, clinician, and hospital characteristics associated with cardiac resynchronization therapy defibrillator use and determine the extent of hospital-level variation in this use among guideline-eligible patients undergoing implantable cardioverter defibrillator placement.
This study of pooled data from patients in 4 randomized clinical trials characterizes variability in proprotein convertase subtilisin kexin type 9 (PCSK9) levels and determines whether the reduction in low-density lipoprotein cholesterol level achieved with evolocumab differs based on PCSK9 levels.
This review explores the epidemiology and pathophysiology of the nexus of atrial fibrillation and type 2 diabetes to provide an evidence-based update of therapy options for patients with both conditions.
This population-based cohort study disaggregates mortality data from the National Center for Health Statistics for different types of cardiovascular disease among the 3 largest US Hispanic subgroups, Mexicans, Puerto Ricans, and Cubans.
This secondary analysis of a randomized clinical trial evaluates the 5-year outcomes of zotarolimus-eluting stents vs everolimus-eluting stents to treat randomized participants and nonenrolled eligible patients with non–ST-segment elevation acute coronary syndromes.
A woman in her late 50s with a history of multiple sclerosis, without traditional atherosclerosis risk factors and not taking medications, presented to the emergency department after having 30 minutes of pain in her left shoulder and vague chest pressure that had already resolved. What would you do next?
This cohort study assesses the structural and electrical progression of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients over time.
This cohort study uses data from the National Inpatient Sample database to examine rates of in-hospital reperfusion and outcomes among renal transplant recipients hospitalized with ST-segment elevation myocardial infarction.
This review assesses the benefits of cardiovascular implantable electronic devices for the detection and treatment of subclinical atrial fibrillation among patients enrolled in clinical studies.
This longitudinal study characterizes myocardial infarctions, including type, identifies causes of type 2 myocardial infarctions, and compares demographic and clinical characteristics among human immunodeficiency virus–infected individuals with type 1 vs type 2 myocardial infarctions.
This study investigates the association between bicuspid aortic valve morphologic findings (raphe vs nonraphe) and the degree of valve dysfunction, presence of aortopathy, and prognosis (including need for aortic valve surgery, aortic dissection, and all-cause mortality).
This study finds that most patients undergoing warfarin therapy for atrial fibrillation discontinue it within the first year, particularly those who have scheduled electrical cardioversion or radiofrequency ablation.
This study examines statin prescription rates among patients with dyslipidemia.